世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

ナノメディシンの世界市場、ナノ分子タイプ別(ナノ粒子、ナノシェル、ナノデバイス、ナノチューブ)、ナノ粒子タイプ別(ポリマーベース、脂質ベース、ナノクリスタル、無機、その他)、用途別(ドラッグデリバリー、ワクチン、診断イメージング、再生医療、その他) 疾患適応症別(腫瘍性疾患、感染症、整形外科疾患、循環器疾患、その他)、地域別、競争予測・機会、2027年


Global Nanomedicine Market, By Nanomolecule Type (Nanoparticles, Nanoshells, Nanodevices, Nanotubes), By Nanoparticle Type (Polymer-based, Lipid-based, Nanocrystals, Inorganic, Others), By Application (Drug Delivery, Vaccines, Diagnostic Imaging, Regenerative Medicine, Others) By Disease Indication (Oncological Diseases, Infectious Diseases, Orthopedic Disorders, Cardiovascular Diseases, Others), By Region and Competition Forecast & Opportunities, 2027

世界のナノメディシン市場は、予測期間である2023年から2027年にかけて8.28%という驚異的なCAGRで成長し、2027年には2億4265万5100米ドルに達すると予想されます。この市場を牽引しているのは、医療費の増大や個... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
TechSci Research
テックサイリサーチ
2022年6月1日 US$4,900
シングルユーザライセンス
ライセンス・価格情報・注文方法はこちら
111 英語

 

サマリー

世界のナノメディシン市場は、予測期間である2023年から2027年にかけて8.28%という驚異的なCAGRで成長し、2027年には2億4265万5100米ドルに達すると予想されます。この市場を牽引しているのは、医療費の増大や個別化医療に対する需要の高まりといった要因です。がんや心血管疾患などの慢性疾患や生活習慣病の世界的な大流行は、さまざまなヘルスケアアプリケーションにおけるナノメディシンの適用を加速しています。また、薬物送達のための新しい解決策を見つけ、薬物の有効性を高めるために、公的機関や民間企業が研究開発活動に対して多額の投資を行っていることも、予測期間中に世界のナノメディシン市場に有利な成長機会を生み出すと期待されています。
ナノメディシンは、体内での薬の代謝を促進するため、がん、認知症、糖尿病などの慢性疾患の治療に非常に有効であると考えられています。ナノメディシンは、体内で薬の代謝を促進するため、がんや認知症、糖尿病などの慢性疾患の治療に非常に有効であると考えられています。DNAプローブ、ナノセンサー、ナノ粒子ベースのイメージング剤などのナノメディカル製品が市場に出回るようになり、需要が高まっています。しかし、ナノメディシンの製造プロセスや研究開発活動に関連する高コストが、予測期間における世界のナノメディシン市場の妨げになる可能性があります。
世界のナノメディシン市場は、ナノ分子タイプ、ナノ粒子タイプ、アプリケーション、疾患適応、地域分布、競争環境に分けられます。アプリケーションに基づき、ナノメディシン市場はドラッグデリバリー、ワクチン、診断イメージング、再生医療、その他に分けられる。ドラッグデリバリーアプリケーションは2021年に市場を支配し、市場全体のシェアの30.23%を獲得しました。このセグメントは今後5年間、その優位性を維持すると予想されます。ドラッグデリバリーアプリケーションにおけるナノメディシンの利点に関する意識の高まりと、疾患の有病率の増加が、ドラッグデリバリーアプリケーション向けナノメディシンの需要を牽引しています。
世界のナノメディシン市場で活動している主な市場プレイヤーは、Pfizer Inc.、Janssen Pharmaceuticals、Sanofi S.A.、Amgen Inc.、Moderna、Novo Nordisk A/S、Genentech、Inc、Celgene Corporation、Vifor Pharma Group、Teva Pharmaceutical Industries Ltd.など。
本レポートで考慮した年数
歴史的年数:2017年~2020年
基準年:2021年
予定年:2022年
予測期間:2023-2027年
本調査の目的
- 2017年から2021年までの世界のナノメディシン市場の過去の成長と市場規模を分析すること。
- 2023年から2027年までの世界のナノメディシン市場の市場規模および2027年までの成長率を推定・予測する。
- 世界のナノメディシン市場をナノ分子タイプ、ナノ粒子タイプ、用途、疾患適応、地域分布、競合環境に分類し予測する。
- 世界のナノメディシン市場の促進要因と課題を特定する。
- 世界のナノメディシン市場における事業拡大、新製品発売、合併、買収などの競争展開を検討する。
- 世界のナノメディシン市場の価格分析を行う。
- 世界のナノメディシン市場で活動する主要企業のプロファイルを特定し分析する。
TechSci Researchは、この調査のために一次調査と徹底的な二次調査の両方を実施しました。最初に、TechSci Researchは、世界中の主要なナノメディシンメーカーのリストを入手しました。その後、TechSci Researchは特定された企業に対して一次調査アンケートを実施しました。インタビュー中に、回答者は競合他社についても尋ねられた。この手法により、TechSci Researchは、二次調査の制限により特定できなかったナノメディシンメーカーを含めることができました。TechSci Research社は、世界のナノメディシン市場で活動するすべての主要企業のナノメディシンメーカー、流通チャネル、存在を世界中で分析しました。
TechSci Research社は、ボトムアップアプローチで世界のナノメディシン市場規模を算出し、様々な地域のデータが記録され、将来的な予測がなされました。TechSci Research社は、これらの値を業界の専門家や企業の代表者から入手し、適切な全体的な市場規模を得るために、これらの製品タイプやアプリケーションの履歴データを分析することによって外部で検証しました。また、企業のウェブサイト、ニュース記事、プレスリリース、企業の年次報告書、投資家のプレゼンテーション、財務報告書などのさまざまな二次資料もTechSci Researchによって調査されました。
主な対象読者
- ナノメディシンメーカー/サプライヤー/ディストリビューター
- 規制当局や政策立案者などの政府機関
- ナノメディシンに関連する団体、フォーラム、アライアンスなど
- 市場調査会社、コンサルティング会社
本調査は、ナノメディシンのメーカー、サプライヤー、流通業者などの業界関係者にとって重要ないくつかの重要な質問に対する答えを提供するのに有用である。本レポートは、関係者が投資を戦略化し、新たな市場機会を活用するのに役立つだろう。

レポートの範囲です:
本レポートでは、世界のナノメディシン市場を以下のカテゴリーに分類し、さらに以下に詳述する業界動向も合わせて紹介しています:
- ナノメディシン市場、ナノ分子タイプ別:
oナノ粒子
o ナノシェル
o ナノデバイス
o ナノチューブ
- ナノメディシン市場、ナノ粒子タイプ別:
o ポリマーベース
o 脂質系
o ナノクリスタル
o 無機質
o その他
- ナノメディシン市場、アプリケーション別
o ドラッグデリバリー
o ワクチン
o 画像診断
o 再生医療
o その他
- ナノメディシン市場、疾患適応別:
オンコロジー疾患
o 感染症
o 整形外科疾患
o 循環器系疾患
o その他
- ナノメディシン市場、地域別
o 北米
 米国
 カナダ
 メキシコ
オーヨーロッパ
 ドイツ
 フランス
 イギリス
 イタリア
 スペイン
 デンマーク
o アジア太平洋
 中国
 日本
 インド
 オーストラリア
 韓国
 マレーシア
 ベトナム
o 南米
 ブラジル
 アルゼンチン
 コロンビア
o 中東・アフリカ
 トルコ
 イスラエル
 南アフリカ
 サウジアラビア
 UAE
 クウェート

競合他社の状況
企業プロフィール:世界のナノメディシン市場に存在する主要企業の詳細な分析。
利用可能なカスタマイズ:
TechSci Researchは、与えられた市場データをもとに、企業の特定のニーズに応じてカスタマイズを提供します。このレポートでは、以下のカスタマイズオプションが利用可能です:
会社情報
- 追加市場プレイヤー(最大5名)の詳細分析およびプロファイリング。

ページTOPに戻る


目次

1. Product Overview
2. Research Methodology
3. Executive Summary
4. Impact of COVID-19 on Global Nanomedicine Market
5. Voice of Customer
5.1. Factors Increasing the demand for Nanomedicine
5.2. Preference, By Nanomolecule Type
5.3. Demand for Nanomedicine, By Indication
5.4. Brand Awareness
6. Global Nanomedicine Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Nanomolecule Type (Nanoparticles, Nanoshells, Nanodevices, Nanotubes)
6.2.1.1. By Nanoparticle Type (Polymer - based, Lipid – based, Nanocrystals, Inorganic, Others)
6.2.2. By Application (Drug Delivery, Vaccines, Diagnostic Imaging, Regenerative Medicine, Others)
6.2.3. By Disease Indication (Oncological Diseases, Infectious Diseases, Orthopedic Disorders, Cardiovascular Diseases, Others)
6.2.4. By Company (2021)
6.2.5. By Region
6.3. Market Map
7. North America Nanomedicine Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Nanomolecule Type (Nanoparticles, Nanoshells, Nanodevices, Nanotubes)
7.2.1.1. By Nanoparticle Type (Polymer - based, Lipid – based, Nanocrystals, Inorganic, Others)
7.2.2. By Application (Drug Delivery, Vaccines, Diagnostic Imaging, Regenerative Medicine, Others)
7.2.3. By Disease Indication (Oncological Diseases, Infectious Diseases, Orthopedic Disorders, Cardiovascular Diseases, Others)
7.2.4. By Country
7.3. North America: Country Analysis
7.3.1. United States Nanomedicine Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Nanomolecule Type
7.3.1.2.1.1. By Nanoparticle Type
7.3.1.2.2. By Application
7.3.1.2.3. By Disease Indication
7.3.2. Canada Nanomedicine Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Nanomolecule Type
7.3.2.2.1.1. By Nanoparticle Type
7.3.2.2.2. By Application
7.3.2.2.3. By Disease Indication
7.3.3. Mexico Nanomedicine Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Nanomolecule Type
7.3.3.2.1.1. By Nanoparticle Type
7.3.3.2.2. By Application
7.3.3.2.3. By Disease Indication
8. Europe Nanomedicine Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Nanomolecule Type (Nanoparticles, Nanoshells, Nanodevices, Nanotubes)
8.2.1.1. By Nanoparticle Type (Polymer - based, Lipid – based, Nanocrystals, Inorganic, Others)
8.2.2. By Application (Drug Delivery, Vaccines, Diagnostic Imaging, Regenerative Medicine, Others)
8.2.3. By Disease Indication (Oncological Diseases, Infectious Diseases, Orthopedic Disorders, Cardiovascular Diseases, Others)
8.2.4. By Country
8.3. Europe: Country Analysis
8.3.1. Germany Nanomedicine Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Nanomolecule Type
8.3.1.2.1.1. By Nanoparticle Type
8.3.1.2.2. By Application
8.3.1.2.3. By Disease Indication
8.3.2. France Nanomedicine Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Nanomolecule Type
8.3.2.2.1.1. By Nanoparticle Type
8.3.2.2.2. By Application
8.3.2.2.3. By Disease Indication
8.3.3. United Kingdom Nanomedicine Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Nanomolecule Type
8.3.3.2.1.1. By Nanoparticle Type
8.3.3.2.2. By Application
8.3.3.2.3. By Disease Indication
8.3.4. Italy Nanomedicine Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Nanomolecule Type
8.3.4.2.1.1. By Nanoparticle Type
8.3.4.2.2. By Application
8.3.4.2.3. By Disease Indication
8.3.5. Spain Nanomedicine Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Nanomolecule Type
8.3.5.2.1.1. By Nanoparticle Type
8.3.5.2.2. By Application
8.3.5.2.3. By Disease Indication
8.3.6. Denmark Nanomedicine Market Outlook
8.3.6.1. Market Size & Forecast
8.3.6.1.1. By Value
8.3.6.2. Market Share & Forecast
8.3.6.2.1. By Nanomolecule Type
8.3.6.2.1.1. By Nanoparticle Type
8.3.6.2.2. By Application
8.3.6.2.3. By Disease Indication
9. Asia Pacific Nanomedicine Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Nanomolecule Type (Nanoparticles, Nanoshells, Nanodevices, Nanotubes)
9.2.1.1. By Nanoparticle Type (Polymer - based, Lipid – based, Nanocrystals, Inorganic, Others)
9.2.2. By Application (Drug Delivery, Vaccines, Diagnostic Imaging, Regenerative Medicine, Others)
9.2.3. By Disease Indication (Oncological Diseases, Infectious Diseases, Orthopedic Disorders, Cardiovascular Diseases, Others)
9.2.4. By Country
9.3. Asia Pacific: Country Analysis
9.3.1. China Nanomedicine Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Nanomolecule Type
9.3.1.2.1.1. By Nanoparticle Type
9.3.1.2.2. By Application
9.3.1.2.3. By Disease Indication
9.3.2. Japan Nanomedicine Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Nanomolecule Type
9.3.2.2.1.1. By Nanoparticle Type
9.3.2.2.2. By Application
9.3.2.2.3. By Disease Indication
9.3.3. India Nanomedicine Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Nanomolecule Type
9.3.3.2.1.1. By Nanoparticle Type
9.3.3.2.2. By Application
9.3.3.2.3. By Disease Indication
9.3.4. Australia Nanomedicine Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Nanomolecule Type
9.3.4.2.1.1. By Nanoparticle Type
9.3.4.2.2. By Application
9.3.4.2.3. By Disease Indication
9.3.5. South Korea Nanomedicine Market Outlook
9.3.5.1. Market Size & Forecast
9.3.5.1.1. By Value
9.3.5.2. Market Share & Forecast
9.3.5.2.1. By Nanomolecule Type
9.3.5.2.1.1. By Nanoparticle Type
9.3.5.2.2. By Application
9.3.5.2.3. By Disease Indication
9.3.6. Malaysia Nanomedicine Market Outlook
9.3.6.1. Market Size & Forecast
9.3.6.1.1. By Value
9.3.6.2. Market Share & Forecast
9.3.6.2.1. By Nanomolecule Type
9.3.6.2.1.1. By Nanoparticle Type
9.3.6.2.2. By Application
9.3.6.2.3. By Disease Indication
9.3.7. Vietnam Nanomedicine Market Outlook
9.3.7.1. Market Size & Forecast
9.3.7.1.1. By Value
9.3.7.2. Market Share & Forecast
9.3.7.2.1. By Nanomolecule Type
9.3.7.2.1.1. By Nanoparticle Type
9.3.7.2.2. By Application
9.3.7.2.3. By Disease Indication
10. South America Nanomedicine Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Nanomolecule Type (Nanoparticles, Nanoshells, Nanodevices, Nanotubes)
10.2.1.1. By Nanoparticle Type (Polymer - based, Lipid – based, Nanocrystals, Inorganic, Others)
10.2.2. By Application (Drug Delivery, Vaccines, Diagnostic Imaging, Regenerative Medicine, Others)
10.2.3. By Disease Indication (Oncological Diseases, Infectious Diseases, Orthopedic Disorders, Cardiovascular Diseases, Others)
10.2.4. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Nanomedicine Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Nanomolecule Type
10.3.1.2.1.1. By Nanoparticle Type
10.3.1.2.2. By Application
10.3.1.2.3. By Disease Indication
10.3.2. Argentina Nanomedicine Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Nanomolecule Type
10.3.2.2.1.1. By Nanoparticle Type
10.3.2.2.2. By Application
10.3.2.2.3. By Disease Indication
10.3.3. Colombia Nanomedicine Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Nanomolecule Type
10.3.3.2.1.1. By Nanoparticle Type
10.3.3.2.2. By Application
10.3.3.2.3. By Disease Indication
11. Middle East and Africa Nanomedicine Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Nanomolecule Type (Nanoparticles, Nanoshells, Nanodevices, Nanotubes)
11.2.1.1. By Nanoparticle Type (Polymer - based, Lipid – based, Nanocrystals, Inorganic, Others)
11.2.2. By Application (Drug Delivery, Vaccines, Diagnostic Imaging, Regenerative Medicine, Others)
11.2.3. By Disease Indication (Oncological Diseases, Infectious Diseases, Orthopedic Disorders, Cardiovascular Diseases, Others)
11.2.4. By Country
11.3. Middle East and Africa: Country Analysis
11.3.1. Turkey Nanomedicine Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Nanomolecule Type
11.3.1.2.1.1. By Nanoparticle Type
11.3.1.2.2. By Application
11.3.1.2.3. By Disease Indication
11.3.2. Israel Nanomedicine Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Nanomolecule Type
11.3.2.2.1.1. By Nanoparticle Type
11.3.2.2.2. By Application
11.3.2.2.3. By Disease Indication
11.3.3. South Africa Nanomedicine Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Nanomolecule Type
11.3.3.2.1.1. By Nanoparticle Type
11.3.3.2.2. By Application
11.3.3.2.3. By Disease Indication
11.3.4. Saudi Arabia Nanomedicine Market Outlook
11.3.4.1. Market Size & Forecast
11.3.4.1.1. By Value
11.3.4.2. Market Share & Forecast
11.3.4.2.1. By Nanomolecule Type
11.3.4.2.1.1. By Nanoparticle Type
11.3.4.2.2. By Application
11.3.4.2.3. By Disease Indication
11.3.5. UAE Nanomedicine Market Outlook
11.3.5.1. Market Size & Forecast
11.3.5.1.1. By Value
11.3.5.2. Market Share & Forecast
11.3.5.2.1. By Nanomolecule Type
11.3.5.2.1.1. By Nanoparticle Type
11.3.5.2.2. By Application
11.3.5.2.3. By Disease Indication
11.3.6. Kuwait Nanomedicine Market Outlook
11.3.6.1. Market Size & Forecast
11.3.6.1.1. By Value
11.3.6.2. Market Share & Forecast
11.3.6.2.1. By Nanomolecule Type
11.3.6.2.1.1. By Nanoparticle Type
11.3.6.2.2. By Application
11.3.6.2.3. By Disease Indication
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends and Developments
14. Competitive Landscape
14.1. Pfizer Inc.
14.2. Janssen Pharmaceuticals
14.3. Sanofi S.A.
14.4. Amgen Inc.
14.5. Moderna, Inc.
14.6. Novo Nordisk A/S
14.7. Genentech, Inc
14.8. Celgene Corporation
14.9. Vifor Pharma Ltd.
14.10. Teva Pharmaceutical Industries Ltd.
15. Strategic Recommendations

 

ページTOPに戻る


 

Summary

The global nanomedicine market is expected to grow at an impressive CAGR of 8.28% in the forecast period, 2023-2027, to reach USD242655.19 million by 2027. The market is driven by the factors such as the growing healthcare expenditure and increased demand for personalized medicines. The massive prevalence of chronic and lifestyle disorders such as cancer and cardiovascular diseases across the globe is accelerating the application of nanomedicine in various healthcare applications. Also, the high-end investments in research and development activities by public and private players to find novel solutions for drug delivery and increase the effectiveness of drugs are expected to create lucrative growth opportunities for the global nanomedicine market in the forecast period.
Nanomedicines are considered very effective in treating chronic diseases such as cancer, dementia, and diabetes as they fuel the metabolism of medications in the body. They deliver the drugs at the target site in the right proportion. The market's availability of nanomedical products such as DNA probes, nanosensors, and nanoparticle-based imaging agents is increasing the demand. However, the high cost associated with the nanomedicine manufacturing process and research and development activities may hinder the global nanomedicine market in the forecast period.
The global nanomedicine market is divided into nano molecule type, nanoparticles type, application, disease indication, regional distribution, and competitive landscape. Based on application, the nanomedicine market is divided into drug delivery, vaccines, diagnostic imaging, regenerative medicine, and others. Drug delivery applications dominated the market in 2021 and captured 30.23% of the overall market share. This segment is expected to maintain its dominance over the next five years. The rise in awareness about the benefits of nanomedicine in drug delivery applications and the increased prevalence of diseases drives the demand for nanomedicines for drug delivery applications.
The major market players operating in the global nanomedicine market are Pfizer Inc., Janssen Pharmaceuticals, Sanofi S.A., Amgen Inc., Moderna, Inc., Novo Nordisk A/S, Genentech, Inc., Celgene Corporation, Vifor Pharma Group, Teva Pharmaceutical Industries Ltd., among others.
Years considered for this report:
Historical Years: 2017-2020
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2023-2027
Objective of the Study:
• To analyze the historical growth and the market size of the global nanomedicine market from 2017 to 2021.
• To estimate and forecast the market size of the global nanomedicine market from 2023 to 2027 and growth rate until 2027.
• To classify and forecast the global nanomedicine market is divided into nanomolecule type, nanoparticles type, application, disease indication, regional distribution, and competitive landscape.
• To identify drivers and challenges for the global nanomedicine market.
• To examine competitive developments such as expansions, new product launches, mergers, and acquisitions, etc., in the global nanomedicine market.
• To conduct pricing analysis for the global nanomedicine market.
• To identify and analyze the profile of leading players operating in global nanomedicine market.
TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of leading nanomedicine manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the nanomedicine manufacturers who could not be identified due to the limitations of secondary research. TechSci Research analyzed the nanomedicine manufacturers, distribution channels and presence of all major players operating in the global nanomedicine market all over the world.
TechSci Research calculated the global nanomedicine market size using a bottom-up approach, where data for various regions was recorded and forecasted for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.
Key Target Audience:
• Nanomedicine manufacturers/ suppliers/ distributors
• Government bodies such as regulating authorities and policy makers
• Organizations, forums, and alliances related to nanomedicine
• Market research and consulting firms
The study is useful in providing answers to several critical questions that are important for industry stakeholders such as nanomedicine manufacturers, suppliers, distributors, and other stakeholders. The report would enable the stakeholders in strategizing investments and capitalizing on emerging market opportunities.

Report Scope:
In this report, global nanomedicine market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
• Nanomedicine Market, By Nanomolecule Type:
o Nanoparticles
o Nanoshells
o Nanodevices
o Nanotubes
• Nanomedicine Market, By Nanoparticles Type:
o Polymer-based
o Lipid-based
o Nanocrystals
o Inorganic
o Others
• Nanomedicine Market, By Application:
o Drug Delivery
o Vaccines
o Diagnostic Imaging
o Regenerative Medicine
o Others
• Nanomedicine Market, By Disease Indication:
o Oncological Diseases
o Infectious Diseases
o Orthopedic Disorders
o Cardiovascular Diseases
o Others
• Nanomedicine Market, By Region:
o North America
 United States
 Canada
 Mexico
o Europe
 Germany
 France
 United Kingdom
 Italy
 Spain
 Denmark
o Asia Pacific
 China
 Japan
 India
 Australia
 South Korea
 Malaysia
 Vietnam
o South America
 Brazil
 Argentina
 Colombia
o Middle East & Africa
 Turkey
 Israel
 South Africa
 Saudi Arabia
 UAE
 Kuwait

Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in global nanomedicine market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
• Detailed analysis and profiling of additional market players (up to five).



ページTOPに戻る


Table of Contents

1. Product Overview
2. Research Methodology
3. Executive Summary
4. Impact of COVID-19 on Global Nanomedicine Market
5. Voice of Customer
5.1. Factors Increasing the demand for Nanomedicine
5.2. Preference, By Nanomolecule Type
5.3. Demand for Nanomedicine, By Indication
5.4. Brand Awareness
6. Global Nanomedicine Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Nanomolecule Type (Nanoparticles, Nanoshells, Nanodevices, Nanotubes)
6.2.1.1. By Nanoparticle Type (Polymer - based, Lipid – based, Nanocrystals, Inorganic, Others)
6.2.2. By Application (Drug Delivery, Vaccines, Diagnostic Imaging, Regenerative Medicine, Others)
6.2.3. By Disease Indication (Oncological Diseases, Infectious Diseases, Orthopedic Disorders, Cardiovascular Diseases, Others)
6.2.4. By Company (2021)
6.2.5. By Region
6.3. Market Map
7. North America Nanomedicine Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Nanomolecule Type (Nanoparticles, Nanoshells, Nanodevices, Nanotubes)
7.2.1.1. By Nanoparticle Type (Polymer - based, Lipid – based, Nanocrystals, Inorganic, Others)
7.2.2. By Application (Drug Delivery, Vaccines, Diagnostic Imaging, Regenerative Medicine, Others)
7.2.3. By Disease Indication (Oncological Diseases, Infectious Diseases, Orthopedic Disorders, Cardiovascular Diseases, Others)
7.2.4. By Country
7.3. North America: Country Analysis
7.3.1. United States Nanomedicine Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Nanomolecule Type
7.3.1.2.1.1. By Nanoparticle Type
7.3.1.2.2. By Application
7.3.1.2.3. By Disease Indication
7.3.2. Canada Nanomedicine Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Nanomolecule Type
7.3.2.2.1.1. By Nanoparticle Type
7.3.2.2.2. By Application
7.3.2.2.3. By Disease Indication
7.3.3. Mexico Nanomedicine Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Nanomolecule Type
7.3.3.2.1.1. By Nanoparticle Type
7.3.3.2.2. By Application
7.3.3.2.3. By Disease Indication
8. Europe Nanomedicine Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Nanomolecule Type (Nanoparticles, Nanoshells, Nanodevices, Nanotubes)
8.2.1.1. By Nanoparticle Type (Polymer - based, Lipid – based, Nanocrystals, Inorganic, Others)
8.2.2. By Application (Drug Delivery, Vaccines, Diagnostic Imaging, Regenerative Medicine, Others)
8.2.3. By Disease Indication (Oncological Diseases, Infectious Diseases, Orthopedic Disorders, Cardiovascular Diseases, Others)
8.2.4. By Country
8.3. Europe: Country Analysis
8.3.1. Germany Nanomedicine Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Nanomolecule Type
8.3.1.2.1.1. By Nanoparticle Type
8.3.1.2.2. By Application
8.3.1.2.3. By Disease Indication
8.3.2. France Nanomedicine Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Nanomolecule Type
8.3.2.2.1.1. By Nanoparticle Type
8.3.2.2.2. By Application
8.3.2.2.3. By Disease Indication
8.3.3. United Kingdom Nanomedicine Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Nanomolecule Type
8.3.3.2.1.1. By Nanoparticle Type
8.3.3.2.2. By Application
8.3.3.2.3. By Disease Indication
8.3.4. Italy Nanomedicine Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Nanomolecule Type
8.3.4.2.1.1. By Nanoparticle Type
8.3.4.2.2. By Application
8.3.4.2.3. By Disease Indication
8.3.5. Spain Nanomedicine Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Nanomolecule Type
8.3.5.2.1.1. By Nanoparticle Type
8.3.5.2.2. By Application
8.3.5.2.3. By Disease Indication
8.3.6. Denmark Nanomedicine Market Outlook
8.3.6.1. Market Size & Forecast
8.3.6.1.1. By Value
8.3.6.2. Market Share & Forecast
8.3.6.2.1. By Nanomolecule Type
8.3.6.2.1.1. By Nanoparticle Type
8.3.6.2.2. By Application
8.3.6.2.3. By Disease Indication
9. Asia Pacific Nanomedicine Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Nanomolecule Type (Nanoparticles, Nanoshells, Nanodevices, Nanotubes)
9.2.1.1. By Nanoparticle Type (Polymer - based, Lipid – based, Nanocrystals, Inorganic, Others)
9.2.2. By Application (Drug Delivery, Vaccines, Diagnostic Imaging, Regenerative Medicine, Others)
9.2.3. By Disease Indication (Oncological Diseases, Infectious Diseases, Orthopedic Disorders, Cardiovascular Diseases, Others)
9.2.4. By Country
9.3. Asia Pacific: Country Analysis
9.3.1. China Nanomedicine Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Nanomolecule Type
9.3.1.2.1.1. By Nanoparticle Type
9.3.1.2.2. By Application
9.3.1.2.3. By Disease Indication
9.3.2. Japan Nanomedicine Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Nanomolecule Type
9.3.2.2.1.1. By Nanoparticle Type
9.3.2.2.2. By Application
9.3.2.2.3. By Disease Indication
9.3.3. India Nanomedicine Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Nanomolecule Type
9.3.3.2.1.1. By Nanoparticle Type
9.3.3.2.2. By Application
9.3.3.2.3. By Disease Indication
9.3.4. Australia Nanomedicine Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Nanomolecule Type
9.3.4.2.1.1. By Nanoparticle Type
9.3.4.2.2. By Application
9.3.4.2.3. By Disease Indication
9.3.5. South Korea Nanomedicine Market Outlook
9.3.5.1. Market Size & Forecast
9.3.5.1.1. By Value
9.3.5.2. Market Share & Forecast
9.3.5.2.1. By Nanomolecule Type
9.3.5.2.1.1. By Nanoparticle Type
9.3.5.2.2. By Application
9.3.5.2.3. By Disease Indication
9.3.6. Malaysia Nanomedicine Market Outlook
9.3.6.1. Market Size & Forecast
9.3.6.1.1. By Value
9.3.6.2. Market Share & Forecast
9.3.6.2.1. By Nanomolecule Type
9.3.6.2.1.1. By Nanoparticle Type
9.3.6.2.2. By Application
9.3.6.2.3. By Disease Indication
9.3.7. Vietnam Nanomedicine Market Outlook
9.3.7.1. Market Size & Forecast
9.3.7.1.1. By Value
9.3.7.2. Market Share & Forecast
9.3.7.2.1. By Nanomolecule Type
9.3.7.2.1.1. By Nanoparticle Type
9.3.7.2.2. By Application
9.3.7.2.3. By Disease Indication
10. South America Nanomedicine Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Nanomolecule Type (Nanoparticles, Nanoshells, Nanodevices, Nanotubes)
10.2.1.1. By Nanoparticle Type (Polymer - based, Lipid – based, Nanocrystals, Inorganic, Others)
10.2.2. By Application (Drug Delivery, Vaccines, Diagnostic Imaging, Regenerative Medicine, Others)
10.2.3. By Disease Indication (Oncological Diseases, Infectious Diseases, Orthopedic Disorders, Cardiovascular Diseases, Others)
10.2.4. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Nanomedicine Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Nanomolecule Type
10.3.1.2.1.1. By Nanoparticle Type
10.3.1.2.2. By Application
10.3.1.2.3. By Disease Indication
10.3.2. Argentina Nanomedicine Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Nanomolecule Type
10.3.2.2.1.1. By Nanoparticle Type
10.3.2.2.2. By Application
10.3.2.2.3. By Disease Indication
10.3.3. Colombia Nanomedicine Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Nanomolecule Type
10.3.3.2.1.1. By Nanoparticle Type
10.3.3.2.2. By Application
10.3.3.2.3. By Disease Indication
11. Middle East and Africa Nanomedicine Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Nanomolecule Type (Nanoparticles, Nanoshells, Nanodevices, Nanotubes)
11.2.1.1. By Nanoparticle Type (Polymer - based, Lipid – based, Nanocrystals, Inorganic, Others)
11.2.2. By Application (Drug Delivery, Vaccines, Diagnostic Imaging, Regenerative Medicine, Others)
11.2.3. By Disease Indication (Oncological Diseases, Infectious Diseases, Orthopedic Disorders, Cardiovascular Diseases, Others)
11.2.4. By Country
11.3. Middle East and Africa: Country Analysis
11.3.1. Turkey Nanomedicine Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Nanomolecule Type
11.3.1.2.1.1. By Nanoparticle Type
11.3.1.2.2. By Application
11.3.1.2.3. By Disease Indication
11.3.2. Israel Nanomedicine Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Nanomolecule Type
11.3.2.2.1.1. By Nanoparticle Type
11.3.2.2.2. By Application
11.3.2.2.3. By Disease Indication
11.3.3. South Africa Nanomedicine Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Nanomolecule Type
11.3.3.2.1.1. By Nanoparticle Type
11.3.3.2.2. By Application
11.3.3.2.3. By Disease Indication
11.3.4. Saudi Arabia Nanomedicine Market Outlook
11.3.4.1. Market Size & Forecast
11.3.4.1.1. By Value
11.3.4.2. Market Share & Forecast
11.3.4.2.1. By Nanomolecule Type
11.3.4.2.1.1. By Nanoparticle Type
11.3.4.2.2. By Application
11.3.4.2.3. By Disease Indication
11.3.5. UAE Nanomedicine Market Outlook
11.3.5.1. Market Size & Forecast
11.3.5.1.1. By Value
11.3.5.2. Market Share & Forecast
11.3.5.2.1. By Nanomolecule Type
11.3.5.2.1.1. By Nanoparticle Type
11.3.5.2.2. By Application
11.3.5.2.3. By Disease Indication
11.3.6. Kuwait Nanomedicine Market Outlook
11.3.6.1. Market Size & Forecast
11.3.6.1.1. By Value
11.3.6.2. Market Share & Forecast
11.3.6.2.1. By Nanomolecule Type
11.3.6.2.1.1. By Nanoparticle Type
11.3.6.2.2. By Application
11.3.6.2.3. By Disease Indication
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends and Developments
14. Competitive Landscape
14.1. Pfizer Inc.
14.2. Janssen Pharmaceuticals
14.3. Sanofi S.A.
14.4. Amgen Inc.
14.5. Moderna, Inc.
14.6. Novo Nordisk A/S
14.7. Genentech, Inc
14.8. Celgene Corporation
14.9. Vifor Pharma Ltd.
14.10. Teva Pharmaceutical Industries Ltd.
15. Strategic Recommendations

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(バイオ薬物)の最新刊レポート

TechSci Research 社の最新刊レポート


よくあるご質問


TechSci Research社はどのような調査会社ですか?


テックサイリサーチ(TechSci Research)は、カナダ、英国、インドに拠点を持ち、化学、IT、環境、消費財と小売、自動車、エネルギーと発電の市場など、多様な産業や地域を対象とした調査・出版活... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/07/22 10:26

158.54 円

173.12 円

207.67 円

ページTOPに戻る